Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlation between c-Met and ALDH1 contributes to the survival and tumor-sphere formation of ALDH1 positive breast cancer stem cells and predicts poor clinical outcome in breast cancer.
Nozaki Y, Tamori S, Inada M, Katayama R, Nakane H, Minamishima O, Onodera Y, Abe M, Shiina S, Tamura K, Kodama D, Sato K, Hara Y, Abe R, Takasawa R, Yoshimori A, Shinomiya N, Tanuma SI, Akimoto K. Nozaki Y, et al. Among authors: tamori s. Genes Cancer. 2017 Jul;8(7-8):628-639. doi: 10.18632/genesandcancer.148. Genes Cancer. 2017. PMID: 28966724 Free PMC article.
Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells.
Tamori S, Nozaki Y, Motomura H, Nakane H, Katayama R, Onaga C, Kikuchi E, Shimada N, Suzuki Y, Noike M, Hara Y, Sato K, Sato T, Yamamoto K, Hanawa T, Imai M, Abe R, Yoshimori A, Takasawa R, Tanuma SI, Akimoto K. Tamori S, et al. Oncotarget. 2018 Nov 23;9(92):36515-36529. doi: 10.18632/oncotarget.26369. eCollection 2018 Nov 23. Oncotarget. 2018. PMID: 30559934 Free PMC article.
High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
Nozaki Y, Motomura H, Tamori S, Kimura Y, Onaga C, Kanai S, Ishihara Y, Ozaki A, Hara Y, Harada Y, Mano Y, Sato T, Sato K, Sasaki K, Ishiguro H, Ohno S, Akimoto K. Nozaki Y, et al. Among authors: tamori s. PLoS One. 2020 Jul 13;15(7):e0235747. doi: 10.1371/journal.pone.0235747. eCollection 2020. PLoS One. 2020. PMID: 32658903 Free PMC article.
Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets for late-stage breast cancer.
Motomura H, Ozaki A, Tamori S, Onaga C, Nozaki Y, Waki Y, Takasawa R, Yoshizawa K, Mano Y, Sato T, Sasaki K, Ishiguro H, Miyagi Y, Nagashima Y, Yamamoto K, Sato K, Hanawa T, Tanuma SI, Ohno S, Akimoto K. Motomura H, et al. Among authors: tamori s. Oncol Lett. 2021 Jul;22(1):547. doi: 10.3892/ol.2021.12808. Epub 2021 May 24. Oncol Lett. 2021. PMID: 34093768 Free PMC article.
GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.
Motomura H, Tamori S, Yatani MA, Namiki A, Onaga C, Ozaki A, Takasawa R, Mano Y, Sato T, Hara Y, Sato K, Xiong Y, Harada Y, Hanawa T, Tanuma SI, Sasaki K, Ohno S, Akimoto K. Motomura H, et al. Among authors: tamori s. Anticancer Res. 2021 Dec;41(12):5959-5971. doi: 10.21873/anticanres.15415. Anticancer Res. 2021. PMID: 34848450
High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer.
Ozaki A, Motomura H, Tamori S, Onaga C, Nagashima Y, Kotori M, Matsuda C, Matsuda A, Mochizuki N, Sato T, Hara Y, Sato K, Miyagi Y, Nagashima Y, Hanawa T, Harada Y, Xiong Y, Sasaki K, Ohno S, Akimoto K. Ozaki A, et al. Among authors: tamori s. Anticancer Res. 2022 Jul;42(7):3299-3312. doi: 10.21873/anticanres.15818. Anticancer Res. 2022. PMID: 35790283
34 results